Concepedia

Mohini Rajasagi

MR

Statistics

Publications

5

Citations

1.1K

H-Index

5

Active since

2012

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Massachusetts General Hospital

Brigham and Women's Hospital

Mohini Rajasagi is an author at Harvard University specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

2012–2020

5

Publications

5

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

Sachet A. Shukla, Michael S. Rooney, Mohini Rajasagi et al. · Nature Biotechnology · 2015 · 670 citations · Full text

, , +11

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

Mohini Rajasagi, Sachet A. Shukla, Edward F. Fritsch et al. · Blood · 2014 · 303 citations · Full text

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Masayasu Naito, Ursula Hainz, Ute Burkhardt et al. · Cancer Immunology Immunotherapy · 2012 · 37 citations · Full text

1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC

M-J. Ahn, Jiaxin Niu, Dongwook Kim et al. · Annals of Oncology · 2020 · 29 citations

, , +7

1410P Safety and efficacy of vibostolimab, an anti-TIGIT antibody, plus pembrolizumab in patients with anti-PD-1/PD-L1-naive NSCLC

Jiaxin Niu, Adnan Nagrial, Mark Voskoboynik et al. · Annals of Oncology · 2020 · 22 citations

, , +6

1–5 of 5